Nirvanappa, A. C., Mohan, C. D., Rangappa, S., Ananda, H., Sukhorukov, A. Y., Shanmugam, M. K., . . . Rangappa, K. S. (2017). Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. PLoS One.
Dyfyniad Arddull ChicagoNirvanappa, Anilkumar C., et al. "Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PLoS One 2017.
Dyfyniad MLANirvanappa, Anilkumar C., et al. "Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PLoS One 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.